Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-09-01
著者
-
Hess Georg
3rd Medical Department Johannes Gutenberg-university
-
Ullmann Andrew
3rd Medical Department Johannes Gutenberg-university
-
Fischer Thomas
3rd Medical Department Johannes Gutenberg-university
-
KOLBE Karin
3rd Medical Department, Johannes Gutenberg-University
-
FRIEDRICH-FREKSA A.
Institute for Clinical Genetics
-
MEYER Ralf
3rd Medical Department, Johannes Gutenberg-University
-
GSCHAIDMEIER Harald
Novartis Pharma
-
HUBER Christoph
3rd Medical Department, Johannes Gutenberg-University
-
Huber Christoph
3rd Medical Department Johannes Gutenberg-university
-
Kolbe Karin
3rd Medical Department Johannes Gutenberg-university
-
Meyer Ralf
3rd Medical Department Johannes Gutenberg-university
関連論文
- Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation
- Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation